cabozantinib
exelixis
['atlantis', 'bladder', 'cabozantinib', ' uc,(-ucsd),(-ucsf),']
robert j. jones updated us today on the atlantis trial in the genitourinary cancer kidney and bladder session, concluding that this study does not support further investigation cabozantinib as a maintenance therapy after platinum based chemo in patients with adv. uc. #asco22
Independent and international experts in GenitoUrinary (GU) oncology. Part of https://t.co/QAbKORwRcf